ReviewPolymers2026
Structure-Property Relationships and Surface Engineering of Natural Biopolymers for Triboelectric Applications: The Role of Additive Manufacturing.
Review in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This comprehensive review aims to cover the surface tribology and triboelectric properties of additively manufactured (AM) natural biopolymers, including cellulose, chitosan (CS) and silk fibroin (SF), in biomedical interface engineering. While these sustainable materials exhibit innate biocompatibility and tribopositivity, their baseline triboelectric performance demands targeted surface engineering. We synthesize key physical mechanisms governing charge generation, emphasizing how controlled surface roughness, hierarchical porosity and nanoscale architectures maximize contact electrification. Furthermore, distinct dielectric and polarity modulation strategies are evaluated across the biopolymer families: cellulose relies heavily on chemical functionalization to overcome weak native polarity; chitosan utilizes ionic coordination and fillers to elevate its relatively low charge density; and silk fibroin achieves exceptional power outputs via highly porous three-dimensional nanocomposite aerogels. AM technologies afford unprecedented spatial control over these biointerfaces but introduce severe processing constraints. Techniques such as those based on extrusion impose strict shear-thinning rheology and rapid crosslinking for cellulose and chitosan, while SF frequently suffers from crystallization-induced nozzle clogging, necessitating photocurable derivatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.